InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Ball Bryan, Directeur Qualité. Insider active across 3 companies, notably Intercept Pharmaceuticals, INC.. In total, 11 reports have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €535k. History available since 11 January 2022. The latest transaction was disclosed on 13 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Ball Bryan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
26,389 股@ US$3.4621.4% 占其流量Common StockSEC:0001766522-26-000011:0
92,460 股@ US$3.6478.6% 占其流量Common StockSEC:0001766522-26-000011:1
50,000 股@ US$3.5728.5% 占其流量Common StockSEC:0001766522-26-000009:0
6,596 股@ US$3.433.6% 占其流量Common StockSEC:0001766522-26-000009:1
366,532 股Common StockSEC:0001766522-26-000005:0
5,000 股Common StockSEC:0001766522-26-000002:0
5,000 股Common StockSEC:0001415889-25-006676:0
436 股@ US$14.577.2% 占其流量Common StockSEC:0001104659-22-079500:0
531 股@ US$17.1916.4% 占其流量Common StockSEC:0001104659-22-045468:0
3,600 股0Common StockSEC:0001104659-22-009549:0
2,455 股@ US$16.8371.3% 占其流量Common StockSEC:0001104659-22-004113:0
11 条申报中的 11 条
About Ball Bryan
Ball Bryan is Director Quality and appears in 11 filings. In the 11 sampled filings, dated from 2022-01-13 to 2026-04-15, the transactions are sales totaling EUR 534842, with recent filings mainly tied to Whitehawk Therapeutics, Inc. and a few transactions at Intercept Pharmaceuticals, INC.
